Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.trsl.2011.11.004 | DOI Listing |
JMIR Cardio
April 2021
Department of Cardiology, Vivantes Hospital Am Urban, Berlin, Germany.
Background: Heart failure (HF) management guided by the measurement of intracardiac and pulmonary pressure values obtained through innovative permanent intracardiac microsensors has been recently proposed as a valid strategy to individualize treatment and anticipate hemodynamic destabilization. These sensors have potential to reduce patient hospitalization rates and optimize quality of life.
Objective: The aim of this study was to evaluate the usability and patients' attitudes toward a new permanent intracardiac device implanted to remotely monitor left intra-atrial pressures (V-LAP, Vectorious Medical Technologies, Tel Aviv, Israel) in patients with chronic HF.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!